
AKBA vs GSK
$AKBA vs $GSK head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
AKBA vs GSK: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Neither kept up with the market over the past year: AKBA -73.6% and GSK +3.5%, against the S&P 500 at +8.8%.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
AKBA vs GSK: the quick read
- ·GSK is the larger company by market cap ($98.26B vs $114M).
- ·AKBA has been more active on our scanner (143 vs 73 alerts in 30 days).
- ·AKBA has the smaller float (265.7M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·They trade in different worlds by share price: AKBA is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·Both stay busy on our scanner, 143 and 73 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: GSK is more than 865x the market cap of AKBA, so the same dollar of news moves AKBA far harder.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·GSK pays a dividend and AKBA does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching AKBA or GSK? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing AKBA and GSK on TheDesperateTrader.
- Is AKBA or GSK the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($98.26B vs $114M). AKBA has been more active on our scanner (143 vs 73 alerts in 30 days). AKBA has the smaller float (265.7M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between AKBA and GSK?
- The differences that matter: GSK is roughly 865x the size of the other by market cap ($114M vs $98.26B); they trade at very different share prices ($0.42 vs $47.80); AKBA sits at 4% of its 52-week range against 13% for GSK; only GSK pays a dividend; our scanner flagged AKBA 143 times in the last 30 days against 73 for GSK. Everything above is measured from the latest completed session and SEC filings.
- Which of AKBA and GSK is more active right now?
- Right now AKBA is at about 0.8x its normal volume and GSK is at about 0.5x, so AKBA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is AKBA or GSK in the stronger trend?
- AKBA is below its 50-day average of $0.73 and below its 200-day average of $1.09; GSK is below its 50-day average of $49.32 and below its 200-day average of $52.31. GSK leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading AKBA or GSK? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore AKBA and GSK comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.